These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
478 related articles for article (PubMed ID: 9525341)
1. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment. Mercer B; Markland F; Minkin C J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341 [TBL] [Abstract][Full Text] [Related]
2. Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis. Trikha M; De Clerck YA; Markland FS Cancer Res; 1994 Sep; 54(18):4993-8. PubMed ID: 7520832 [TBL] [Abstract][Full Text] [Related]
3. Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat. Lark MW; Stroup GB; Dodds RA; Kapadia R; Hoffman SJ; Hwang SM; James IE; Lechowska B; Liang X; Rieman DJ; Salyers KL; Ward K; Smith BR; Miller WH; Huffman WF; Gowen M J Bone Miner Res; 2001 Feb; 16(2):319-27. PubMed ID: 11204432 [TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Xue W; Mizukami I; Todd RF; Petty HR Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008 [TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom. Zhou Q; Hu P; Ritter MR; Swenson SD; Argounova S; Epstein AL; Markland FS Arch Biochem Biophys; 2000 Mar; 375(2):278-88. PubMed ID: 10700384 [TBL] [Abstract][Full Text] [Related]
6. Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis. Lark MW; Stroup GB; Hwang SM; James IE; Rieman DJ; Drake FH; Bradbeer JN; Mathur A; Erhard KF; Newlander KA; Ross ST; Salyers KL; Smith BR; Miller WH; Huffman WF; Gowen M J Pharmacol Exp Ther; 1999 Nov; 291(2):612-7. PubMed ID: 10525079 [TBL] [Abstract][Full Text] [Related]
7. Contortrostatin, a homodimeric disintegrin, binds to integrin alphavbeta5. Zhou Q; Nakada MT; Brooks PC; Swenson SD; Ritter MR; Argounova S; Arnold C; Markland FS Biochem Biophys Res Commun; 2000 Jan; 267(1):350-5. PubMed ID: 10623623 [TBL] [Abstract][Full Text] [Related]
8. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis. Horton MA; Dorey EL; Nesbitt SA; Samanen J; Ali FE; Stadel JM; Nichols A; Greig R; Helfrich MH J Bone Miner Res; 1993 Feb; 8(2):239-47. PubMed ID: 7680185 [TBL] [Abstract][Full Text] [Related]
9. Integrin function in osteoclasts. Rodan SB; Rodan GA J Endocrinol; 1997 Sep; 154 Suppl():S47-56. PubMed ID: 9379137 [TBL] [Abstract][Full Text] [Related]
10. Contortrostatin, a snake venom disintegrin, induces alphavbeta3-mediated tyrosine phosphorylation of CAS and FAK in tumor cells. Ritter MR; Zhou Q; Markland FS J Cell Biochem; 2000 Jul; 79(1):28-37. PubMed ID: 10906753 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody. Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172 [TBL] [Abstract][Full Text] [Related]
12. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells. Sheu JR; Lin CH; Peng HC; Huang TF Proc Soc Exp Biol Med; 1996 Oct; 213(1):71-9. PubMed ID: 8820826 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom. Yang CH; Huang TF; Liu KR; Chen MS; Hung PT Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):843-54. PubMed ID: 8603869 [TBL] [Abstract][Full Text] [Related]
14. Integrin subunit beta3 plays a crucial role in the movement of osteoclasts from the periosteum to the bone surface. Holt I; Marshall MJ J Cell Physiol; 1998 Apr; 175(1):1-9. PubMed ID: 9491775 [TBL] [Abstract][Full Text] [Related]
15. Colombistatin: a disintegrin isolated from the venom of the South American snake (Bothrops colombiensis) that effectively inhibits platelet aggregation and SK-Mel-28 cell adhesion. Sánchez EE; Rodríguez-Acosta A; Palomar R; Lucena SE; Bashir S; Soto JG; Pérez JC Arch Toxicol; 2009 Mar; 83(3):271-9. PubMed ID: 18830584 [TBL] [Abstract][Full Text] [Related]
16. Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat. Crippes BA; Engleman VW; Settle SL; Delarco J; Ornberg RL; Helfrich MH; Horton MA; Nickols GA Endocrinology; 1996 Mar; 137(3):918-24. PubMed ID: 8603604 [TBL] [Abstract][Full Text] [Related]
17. Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model. Beviglia L; Stewart GJ; Niewiarowski S Oncol Res; 1995; 7(1):7-20. PubMed ID: 7549046 [TBL] [Abstract][Full Text] [Related]
19. Echistatin inhibits the migration of murine prefusion osteoclasts and the formation of multinucleated osteoclast-like cells. Nakamura I; Tanaka H; Rodan GA; Duong LT Endocrinology; 1998 Dec; 139(12):5182-93. PubMed ID: 9832459 [TBL] [Abstract][Full Text] [Related]
20. The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats. Yamamoto M; Fisher JE; Gentile M; Seedor JG; Leu CT; Rodan SB; Rodan GA Endocrinology; 1998 Mar; 139(3):1411-9. PubMed ID: 9492078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]